How Your DNA Is Repaired — and Why It Fails in Cancer

Every single day, the DNA in each of your cells takes tens of thousands of hits — from sunlight, radiation, chemicals, and the sheer error rate of copying 3 billion letters. Left unfixed, those become mutations, and enough mutations in the wrong genes become cancer. So you carry a whole toolkit of repair crews. Watch one scan the strand, find a lesion, snip it out and refill it — then hit Repair crew: OFF and watch the damage pile up into permanent mutations while the cancer-risk meter climbs.

Try this: leave it on UV hit and watch the crew fix each thymine dimer — then click Repair crew: OFF (this is what xeroderma pigmentosum or a broken BRCA gene does) and count how fast the mutations lock in.

The Science in Plain Language

1. Your DNA is under fire every second

Picture your genome as an instruction manual 3 billion letters long, copied into almost every one of your ~37 trillion cells. That manual is not stored safely in a vault — it is a soft chemical molecule sitting in a warm, wet, chemically busy cell. Estimates vary, but each cell is thought to suffer on the order of tens of thousands of DNA lesions per day: bases knocked loose, chemical groups stuck on, strands nicked. Add the copying itself — every time a cell divides, it has to transcribe all 3 billion letters — and mistakes are inevitable. The reason you are not riddled with cancer by age five is that repair is happening constantly, quietly, in the background. This animation slows that invisible process down so you can watch a single lesion get found and fixed.

2. Base excision repair — the pothole crew

The most common damage is small and chemical: a single base that has been oxidized (a favourite is 8-oxoguanine, made when free radicals attack), or a base that has spontaneously lost an amino group. Base excision repair (BER) handles these. A specialized enzyme called a glycosylase (for example OGG1) recognizes the one bad base and clips it out, an enzyme called APE1 nicks the backbone, DNA polymerase β drops in the correct base, and a ligase seals the seam. It is like a road crew filling one pothole — fast, local, and running millions of times a day. In the diagram these are the small blue "oxidized base" dots the crew clears almost as fast as they appear.

3. Nucleotide excision repair — cutting out sunburn damage

Ultraviolet light does something nastier: it fuses two neighbouring thymine bases into a bulky, kinked thymine dimer (a cyclobutane pyrimidine dimer) that distorts the whole helix. You cannot fix that by swapping one base. Nucleotide excision repair (NER) instead cuts the damaged strand on both sides of the lesion and lifts out a whole oligonucleotide of roughly 24–32 bases, then uses the intact opposite strand as a template to rebuild the gap. A team of proteins named XPA through XPG does this. People born with a broken NER system have xeroderma pigmentosum (XP): they cannot clear UV damage, so even ordinary sun exposure causes cancers, and their skin-cancer risk is raised roughly a thousandfold, often with skin cancers appearing in early childhood. It is the clearest proof that one repair pathway stands between sunlight and cancer.

4. Mismatch repair — the proofreader

When DNA is copied, the polymerase occasionally pairs the wrong letters — a G where a T belongs. The polymerase's own proofreading catches most of these; the survivors are caught by mismatch repair (MMR), which recognizes the tiny bulge a mismatch makes, identifies the newly made strand (the one with the error), removes the wrong stretch, and re-synthesizes it correctly. Together, proofreading plus mismatch repair push the copying error rate down to roughly one mistake per billion letters. The MMR proteins have names worth knowing: MLH1, MSH2, MSH6, PMS2. Inherit a broken copy of one and you have Lynch syndrome, the most common cause of hereditary colon cancer — lifetime colorectal-cancer risk can run as high as 50–80% depending on the gene, plus raised risk of uterine and other cancers. Tumours that have lost MMR are called "microsatellite-unstable," and — importantly — they often respond dramatically to immunotherapy, because they carry so many mutations that the immune system finally sees them as foreign.

5. Double-strand breaks — and BRCA1/BRCA2

The most dangerous injury of all is a double-strand break, where both rails of the ladder snap in the same place. Now there is no intact template right there to copy from, and a mis-repair can weld the wrong chromosome ends together. The safest fix is homologous recombination (HR): the cell borrows the identical sequence from its sister chromosome (available after DNA has been copied) and uses it as a flawless template. The proteins that run this rescue include BRCA1, BRCA2, and RAD51. These are the very same BRCA genes you have heard about: inherit one broken copy and your cells lose their best double-strand-break repair, which is why hereditary BRCA1/BRCA2 mutations drive breast and ovarian cancer — lifetime breast-cancer risk in carriers is often quoted around 55–70%, versus roughly 12–13% in the general female population.

6. When repair fails, mutations pile up — and cancer follows

Here is the throughline of the whole animation. A single unrepaired lesion is usually harmless. But cancer is a multi-hit disease: it takes several mutations, in specific genes (tumour-suppressors like TP53, and growth-driving oncogenes), stacking up in the same cell lineage. When a repair pathway is missing, every day's damage that should have been erased instead becomes permanent — and the mutation count climbs far faster. That is exactly what you see when you switch the repair crew off: lesions stop getting fixed, they turn dark red, they fill the damage-load bar, and the illustrative cancer-risk meter rises. Losing a repair gene does not cause cancer overnight, but it loads the dice, every day, for a lifetime.

7. Turning the weakness into a weapon — PARP inhibitors

Now the theme runs the other way, and this is one of the most elegant ideas in modern medicine. A cancer that has already lost one repair route is dangerously dependent on its remaining ones. PARP is a protein that helps repair single-strand nicks (part of the base-excision toolkit). Block PARP with a drug — the PARP inhibitors such as olaparib, niraparib, rucaparib, and talazoparib — and those small nicks are left to collide with the replication machinery, where they become double-strand breaks. A normal cell shrugs: it just calls BRCA-driven homologous recombination. But a BRCA-mutant cancer cell has no working homologous recombination, so those breaks are lethal. The drug is nearly harmless to healthy cells and devastating to the tumour — a strategy called synthetic lethality. The cancer's own repair defect became the target that kills it.

8. What is actually true — and what you can do

An honest correction, because this topic breeds myths. Inheriting a BRCA (or Lynch, or XP) mutation is a raised risk, not a diagnosis or a destiny. Many carriers never develop cancer; the numbers are probabilities, and knowing your status is powerful precisely because it unlocks earlier screening, risk-reducing options, and, if cancer ever comes, drugs like PARP inhibitors that are matched to that exact defect. Two more corrections: no antioxidant supplement "prevents DNA damage" wholesale — repair, not supplements, is what protects the genome, and in some trials high-dose antioxidants did nothing helpful or even harmed. And a base tan is not "healthy protection" — a tan is your skin's visible record of DNA damage already done. The genuinely useful moves are ordinary: protect your skin from burning UV, don't smoke (tobacco is a direct DNA-damaging agent), follow recommended screening, and — if cancer runs in your family — ask about genetic counselling. Your repair crews do the heavy lifting; your job is mostly to not overwhelm them.

↑ Back to the animation

Connections

• All Interactive Visualizations
• DNA → Protein
• Free Radicals
• Oncology
• Breast Cancer
• Melanoma